BioCentury
ARTICLE | Clinical News

The gene for CFTR delivered: Protocol for a Phase I/II trial approved

December 6, 1993 8:00 AM UTC

Genzyme Corp. (GENZ) Vical Inc. (VICL) Indication: Cystic fibrosis Product: The gene for CFTR delivered into the nose by aerosol using Vical's cytofectin liposome Status: Protocol for a Phase I/II t...